期刊文献+

替格瑞洛片联合阿司匹林片治疗老年急性ST段抬高型心肌梗死的临床研究 被引量:23

Clinical trial of ticagrelor tablets combined with aspirin tablets in the treatment of elderly patients with acute ST segment elevation myocardial infarction
原文传递
导出
摘要 目的观察替格瑞洛片联合阿司匹林片治疗老年急性ST段抬高型心肌梗死的临床疗效及安全性。方法将170例老年急性ST段抬高型心肌梗死患者随机分为对照组85例和试验组85例。经皮冠状动脉介入治疗(PCI)术前,对照组予以氯吡格雷每次300 mg,qd,口服+阿司匹林每次300 mg,qd,口服;试验组予以替格瑞洛每次180 mg,qd,口服+阿司匹林每次300 mg,qd,口服。2组患者术前均治疗7 d。PCI术后,对照组予以氯吡格雷每次75 mg,qd,口服+阿司匹林每次100 mg,qd,口服;试验组予以替格瑞洛每次90 mg,qd,口服+阿司匹林每次100 mg,qd,口服。2组患者术后均治疗1年。比较2组患者的临床疗效和药物不良反应的发生情况。结果治疗后,试验组和对照组的总有效率分别为94.12%(80例/85例)和81.18%(69例/85例),差异有统计学意义(P<0.05)。试验组出现皮肤瘀点、恶心和呕吐等药物不良反应,对照组出现便秘、紫癜、腹泻和恶心等药物不良反应。试验组和对照组的总药物不良反应发生率分别为4.71%和5.88%,差异无统计学意义(P>0.05)。结论替格瑞洛片联合阿司匹林片治疗老年急性ST段抬高型心肌梗死的临床疗效确切,且不增加药物不良反应的发生率。 Objective To observe the clinical efficacy and safety of ticagrelor tablets combined with aspirin tablets in the treatment of elderly patients with acute ST segment elevation myocardial infarction. Methods A total of 170 elderly patients with acute ST segment elevation myocardial infarction were randomly divided into control and treatment groups with 85 cases per group. Before percutaneous coronary intervention( PCI),control group was given clopidogrel 300 mg per time,qd,orally+ aspirin 300 mg per time,qd,orally. Treatment group was given ticagrelor 180 mg per time,qd,orally + aspirin 300 mg per time,qd,orally. Two groups were treated for 7 days before operation. After PCI operation,control group was given clopidogrel 75 mg per time,qd,orally+ aspirin 100 mg per time,qd,orally. Treatment group was given ticagrelor 90 mg per time,qd,orally + aspirin 100 mg per time,qd,orally. Two groups were treated for 1 year after operation. The clinical efficacy and adverse drug reactions of two groups were compared. Results After treatment,the total effective rates of treatment and control groupswere 94. 12%( 80 cases/85 cases) and 81. 18%( 69 cases/85 cases) with significant difference( P〈0. 05). The adverse drug reactions of treatment group were skin stasis,nausea and vomiting,which in control group were constipation,purpura,diarrhea and nausea. The total incidences of adverse drug reactions in treatment and control groups were4. 71% and 5. 88% without significant difference( P〉0. 05). Conclusion Ticagrelor tablets combined with aspirin tablets have a definitive clinical efficacy in the treatment of elderly patients with acute ST segment elevation myocardial infarction,without increasing the incidence of adverse drug reactions.
作者 冯六六 刘天华 史骏 刘新兵 单蓉 白艳艳 FENG Liu - liu;LIU Tian - hua;SHI Jun;LIU Xin - bing;SHAN Rong;BAI Yan- yan(Internal Medicine - Cardiovascular Department, East City Hospital of Shanghai Yangpu District, Shanghai 200000, Chin)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2018年第13期1494-1496,1507,共4页 The Chinese Journal of Clinical Pharmacology
基金 上海市卫生和计划生育委员会科研课题基金资助项目(201540298)
关键词 替格瑞洛片 阿司匹林片 老年急性ST段抬高型心肌梗死 安全性 ticagrelor tablet aspirin tablet elderly patients with acute ST segment elevation myocardial infarction safety
  • 相关文献

参考文献6

二级参考文献37

  • 1Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 2Bolognese L,Carrabba N,Parodi G,et al.Impact of microvascular dysfunction on left ventricular remodeling and longterm clinical outcome after primary coronary angioplasty for acute myocardial infarction.Circulation,2004,109:1121-1126.
  • 3Hombach V,Grebe O,Merkle N,et al.Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging.Eur Heart J,2005,26:549-557.
  • 4Gibson CM,Cannon CP,Murphy SA,et al.Relationship of the TIMI myocardial perfusion grades,flow grades,frame count,and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.Circulation,2002,105:1909-1913.
  • 5Svilaas T,Vlaar PJ,vander Horst IC,et al.Thrombus aspiration during primary percutaneous coronary intervention.N Engl J Med,2008,358:557-567.
  • 6Steg PG,James S,Harrington RA,et al.Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention:A Platelet Inhibition and Patient Outcomes(PLATO)trial subgroup analysis.Circulation,2010,122:2131-2141.
  • 7Storey RF,Angiolillo DJ,Patil SB,et al.Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes:the PLATO(PLATelet inhibition and patient Outcomes)PLATELET substudy.J Am Coll Cardiol,2010,56:1456-1462.
  • 8O'Gara PT,Kushner FG,Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST elevation myocardial infarction.J Am Coll Cardiol,2013,61:e78-e140.
  • 9Mehran R,Rao SV,Bhatt DL,et al.Standardized bleeding definitions for cardiovascular clinical trials:a consensus report from the Bleeding Academic Research Consortium.Circulation,2011,123:2736-2747.
  • 10Abdi S,Rafizadeh O,Peighambari M,et al.Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention.Res Cardiovasc Med,2015,4:e25414.

共引文献2396

同被引文献182

引证文献23

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部